Author

Yu-Hang Zhang

Peking UniversityORCID 0009-0004-7119-1630Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yu-Hang Zhang2 papers · Macau University of Science and Technology

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Chenyi DaiiD· 1 shared Cui Yi-min· 1 shared Hao LiuiD· 1 shared Huiling ShangiD· 1 shared Ri‐hua XieiD· 1 shared Sen-Tao Pan· 1 shared Tian-Tian Qi· 1 shared Zhenming LiuiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Chenyi DaiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Intratumoral microbiota-derived S1P sensitizes the combination therapy of Capecitabine and Nivolumab

Chenyi Dai, Sen-Tao Pan, Tian-Tian Qi, Huiling Shang, Ri‐hua Xie, Hao Liu, Zhenming Liu, Cui Yi-min, Yu-Hang Zhang

This study identifies how intratumoral microbiota-derived S1P enhances the efficacy of Capecitabine-Nivolumab in CRC by modulating PD-L1 expression and T cell dynamics.

bioRxiv · Jun 5, 2025 · PreprintMicrobiology